SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 5

Identification of Candida species by restriction enzyme analysis

Reyhan YİŞ
Pages
1058–1067
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Restriction digestion with MwoI was able to distinguish between five different species(C. albicans, C. krusei, C. guilliermondii, C. kefyr, and C. glabrata), while BslI digestion could distinguish between C. tropicalis and C.parapsilosis.Conclusion: Restriction enzyme analysis with MwoI and BslI can be used for the identification of Candida species in situations whererapid identification is necessary or conventional methods are problematic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The identification of Candida species isolated from clinical specimens provides information about antifungalsusceptibility and sheds light on the choice of empirical treatment.
📊
Key Findings & Data:In the present study, restriction enzyme analysis of C. albicans andnon-albicans Candida species previously identified by conventional methods was done to evaluate the utility of restriction enzymeanalysis for more rapid and reliable identification of Candida species.Materials and methods: A total of 146 Candida strains isolated from various clinical specimens and ATCC strains were included.
💡
Conclusion & Impact:Restriction digestion with MwoI was able to distinguish between five different species(C. albicans, C. krusei, C. guilliermondii, C. kefyr, and C. glabrata), while BslI digestion could distinguish between C. tropicalis and C.parapsilosis.Conclusion: Restriction enzyme analysis with MwoI and BslI can be used for the identification of Candida species in situations whererapid identification is necessary or conventional methods are problematic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The identification of Candida species isolated from clinical specimens provides information about antifungalsusceptibility and sheds light on the choice of empirical treatment. In the present study, restriction enzyme analysis of C. albicans andnon-albicans Candida species previously identified by conventional methods was done to evaluate the utility of restriction enzymeanalysis for more rapid and reliable identification of Candida species.Materials and methods: A total of 146 Candida strains isolated from various clinical specimens and ATCC strains were included. PCRproducts were digested with MwoI for all species and with BslI for C. parapsilosis and C. tropicalis strains.Results: The strains were identified by conventional methods as 40 C. albicans, 27 C. parapsilosis, 26 C. tropicalis, 25 C. glabrata, 11 C.kefyr, 10 C. krusei, and 7 C. guilliermondii strains. Restriction digestion with MwoI was able to distinguish between five different species(C. albicans, C. krusei, C. guilliermondii, C. kefyr, and C. glabrata), while BslI digestion could distinguish between C. tropicalis and C.parapsilosis.Conclusion: Restriction enzyme analysis with MwoI and BslI can be used for the identification of Candida species in situations whererapid identification is necessary or conventional methods are problematic.

🔖

Cite This Article

YİŞ, R. (2022). Identification of Candida species by restriction enzyme analysis. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 5, 1058–1067. https://ajindex.com/articles/610192

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554. Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol 2014; 31: 42- 48. Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med 2015; 373: 1445-1456
  2. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172-1177.
  3. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Täuber MG, Pittet D et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis 2004; 38: 311-320.
  4. Vallabhaneni S, Mody RK, Walker T, Chiller T. The global burden of fungal diseases. Infect Dis Clin N Am 2016; 30: 1-11.
  5. Concia E, Azzini AM, Conti M. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 2009; 69: 5-14. J. Guinea. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect 2014; 20: 5-10.
  6. Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Muhlethaler K, Pfyffer G, Ruef C, Fehr J, Zbinden R et al. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland. Clin Microbiol Infect 2014; 20: 698-705
  7. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013; 62: 10-24.
  8. Peman J, Bosch M, Canton E, Viudes A, Jarque I, GómezGarcía M, García-Martínez JM, Gobernado M. Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period. Diagn Microbiol Infect Dis 2008; 60: 109-112.
  9. Peman J, Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 2010; 53: 424-433.
  10. Trost A, Graf B, Eucker J, Sezer O, Possinger K, Göbel UB, Adam T. Identification of clinically relevant yeasts by PCR/ RFLP. J Microbiol Meth 2004; 56: 201-211.
  11. Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. Identification of medically importan